Comparison of eradication rates of moxifloxacin–rifabutin triple therapy and bismuth quadruple therapy as second‐line regimens in patients with peptic ulcers

BACKGROUND: Bismuth quadruple (BQ) therapy is known to have poor patient compliance and a complex dosing method, and no appropriate third‐line regimen exists if second‐line BQ therapy fails. In Korea, some alternative regimens have shown unsatisfactory eradication rates. Therefore, we investigated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chang Min, Kim, Seong Je, Hah, Se In, Kwak, Ji Yoon, Choi, Jung Woo, Cho, Hyun Chin, Ha, Chang Yoon, Lee, Ok Jae, Jung, Woon Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399443/
https://www.ncbi.nlm.nih.gov/pubmed/36032516
http://dx.doi.org/10.1002/hsr2.780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399443/
https://www.ncbi.nlm.nih.gov/pubmed/36032516
http://dx.doi.org/10.1002/hsr2.780

Ejemplares similares